The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Pri-Med Southwest: Primary Care is the Key to Improving the Value, Quality of Health Care
Keynote on second day of Pri-Med says that primary care is at the heart of the push to provide high-quality, lower-cost medical care.
Pri-Med Southwest: What Is the Best Approach to Treating Vitamin D Deficiency?
At Pri-Med Southwest, Frank Domino, MD, discussed the dangers of vitamin D deficiency and recommended screening and supplementation for at-risk patients.
Pri-Med Southwest: Motivational Interviewing Can Help Patients Lose Weight
At Pri-Med Southwest, Frank Domino, MD, discussed the benefits of using motivational interviewing techniques when counseling patients on weight loss.
Pri-Med Southwest Attendees Celebrate the Promise of Primary Care
John Goodson, MD, opened Pri-Med Southwest 2011 with a keynote address highlighting primary care innovation and advocacy and advice for future success.
Conference Information: Pri-Med Southwest 2011
Scheduling, session topics, keynote speakers, and other information for physicians planning to attend Pri-Med Southwest 2011.
ACC 2010 Slideshow
AIBD 2010: Strategies for Diagnosing and Managing Microscopic Colitis
The clinical features of microscopic colitis may overlap with those of ulcerative colitis and other bowel conditions.
AIBD 2010: How Do You Explain Risk and Probability to IBD Patients?
Issues of health literacy and numeracy come into play when identifying the best strategies for explaining the risk associated with treatments for IBD.
AIBD 2010: Studies Identify Predictors of IBD Severity, Complications
Several predictors may help clinicians determine which patients with IBD are at risk for more severe disease and potential complications.
AIBD 2010: Do IBD Patients Skip Treatment Due to High Medication Costs?
Although treatment for IBD is expensive, adherence reduces hospitalizations, complications, and other factors that increase the cost of care.
AIBD 2010: Strategies for Managing Loss of Response in IBD Treatment
When IBD patients experience loss of response to therapy, the decision to escalate the dose or switch to other drugs depends on a number of factors.
AIBD 2010: Controversies in IBD: Mucosal Healing vs. Symptom Control
What is the proper balance between mucosal healing and symptom control in treating patients with IBD?
AIBD 2010: What Measure Should Be Used to Assess IBD Outcomes?
Symptoms, not mucosal healing, should be the endpoint used in clinical practice to assess outcomes of patients with inflammatory bowel disease.
AIBD 2010: Promising New Biologics in Development to Treat IBD
Novel biologics in development may provide alternatives to current standards of care in treating patients with refractory inflammatory bowel disease.
AIBD 2010: IBD Treatment Associated with Rare but Serious Complications
Adverse complications associated with IBD treatment may be uncommon, but awareness of these potential side effects is essential for proper management.
AIBD 2010: Will More Uniform Quality of Care Improve IBD Outcomes?
Defining, measuring, and tracking the care gastroenterologists provide to patients with IBD will improve the quality and consistency of care.
AIBD 2010: Only a Minority of At-risk IBD Patients Are Immunized
Most at-risk IBD patients have not received recommended vaccinations, even though 80% of these patients have visited their doctor in the last year.
AIBD 2010: Lessons Learned in the Treatment of Pediatric and Adult IBD
Lessons learned in the management of children with IBD may help gastroenterologists improve the diagnosis and management of adults with the condition.
Information for Attendees of the 2010 AIBD Conference
Scheduling, registration, and other information for attendees of the 2010 Advances in Inflammatory Bowel Diseases, Clinical & Research Conference.
ASN 2010: Insight into the Management of Intradialytic Hypertension
Overlapping clinical definitions of the causes and characteristics of intradialytic hypertension make it a frustrating condition to diagnose and treat
ASN 2010: Gene Variant May Explain High ESRD Rate in African Americans
AASK trial data show mutation in MYH9 gene significantly increases risk of ESRD in African Americans with kidney disease related to hypertension.
ASN 2010: Should JNC 7 Guidelines Be Used in Dialysis Patients?
Prominent cardiologist has some blunt advice for clinicians who are trying to apply JNC 7 guidelines in patients with CKD.
ASN 2010: Risk of Atrial Fibrillation and Other CVD in CKD Patients
CKD stage is a predictor of incident AF and mortality risk in elderly patients. Patients with CKD also frequently exhibit major EKG abnormalities.
ASN 2010: Peginesatide Associated with Increased Risk of CV Events
Peginesatide as effective as standard treatment for anemia in patients with kidney disease, but with higher risk for angina and arrhythmia.
ASN 2010: Lowering LDL in CKD Patients Reduces Risk of CV Events
SHARP trial shows that combination statin therapy in patients with CKD reduces risk of heart attack and stroke without raising cancer risk.
ASN 2010: New Treatment May Reverse the Progression of CKD
By targeting a novel inflammatory pathway, bardoxolone methyl can reduce the stage of chronic kidney disease and improve estimated glomerular filtration rate.
ASN 2010: Race, Poverty Linked to High Kidney Transplant Failure Rates
African Americans living in the poorest neighborhoods have double the risk of kidney transplant failure compared with white non-Hispanic patients.
ASN 2010: Hyponatremia and Risk of Falls and Fractures in the Elderly
Older adults with hyponatremia experience increased rates of fractures and falls, but are not at higher risk for osteoporosis.
ASN 2010: Recent Studies Paint a More Complete Picture of Hyponatremia
Combo therapy with thiazide diuretics may be a major cause of symptomatic hyponatremia, especially in older females with prior cerebrovascular events.
ASN 2010: Tolvaptan Effective on Dilutional Hyponatremia, Neuro Function
Studies show tolvaptan treats significant dilutional hyponatremia and can improve patient performance in neurocognitive and gait tests.